Correlation Analysis of IL-17 Expression and TNF-α, IL-8, IL-6, IL-10 in EPS of Patients with Chronic Prostatitis

Cao Zhibin,Wang Yuantian,Xue Wei,Zheng Guanzhong,Huang Xuyuan,Huang Yiran
DOI: https://doi.org/10.3969/j.issn.1008-0848.2014.02.013
2014-01-01
Abstract:Objective To determine the levels of IL-17, TNF-α, IL-8, IL-6, IL-10 in prostatic secretions of different types patients with chronic prostatitis and analyze their relevance, as well as better understand the role of IL-17 in the development of chronic prostatitis. Methods a total of 110 patients with chronic prostatitis were classified by NIH prostatitis diagnostic criteria including urine routine, routine examination of the prostatic secretions, two glasses of urine culture, and the NIH-CPSI score. The levels of IL-17, TNF-α, IL-8, IL-6 and IL-10 were detected by double antibody sandwich ELISA assay in prostatic secretions of all patients and 30 normal controls. Data analysis was performed by SPSS statistical software. Results The levels of IL-17 in TypeⅡ,Ⅲ-a-andⅢ-b-type CP patients were significantly higher than those of the control group (P<0.01);There was no statistical difference in IL-17 level betweenⅡ-andⅢ-a type (P>0.05);but both groups had significant difference withⅢ-b-type in IL-17 level (P<0.05). IL-17 level was positively correlated with NIH-CPSI score (r=0.462, P<0.05;r=0.571, P<0.01), IL-10 (r=0.289, P<0.05), and IL-6(r=0.26, P<0.05). Conclusion The levels of IL-17 in patients with chronic prostatitis suggests that it may be involved in prostate inflammation.IL-17 is not only the evaluation marker for the severity of chronic prostatitis, but also a new treatment target for chronic prostatitis.
What problem does this paper attempt to address?